Canopy, based in Smiths Falls, Ont., produces and sells medical cannabis and cannabinoid-based consumer products in Canada ...

September saw an intensification of pressure on the economy and markets. Interest rate hikes continued – foretelling economic woes and company troubles. In turn, this has exasperated investors’ ...

Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock price fell 5% on Thursday after the leading cannabis firm announced its acquisition of a competitor at a 66% premium to Wednesday’s closing prices. The ...

Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. Find out why CGC stock ...

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Shares of Canopy Growth Corp. WEED-T dropped by 40 per cent Friday after the company announced it was issuing new shares to reduce its debt load, just one day before a key debt maturity. Canopy said ...

Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Ottawa-area marijuana producer Canopy Growth Corp. (TSX:CGC) is offering to buy Mettrum Health Corp. (TSXV:MT) in a friendly all-stock deal valued at $430 million. Mettrum shareholders will be ...

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

Canopy Growth Corp. said it will replace two of its top executives as the Canadian marijuana firm struggles with a slumping stock price and profitability questions. Chief Financial Officer Mike Lee ...